AngioDynamics (ANGO) Tops Q1 EPS by 5c, Offers Q2 and FY Guidance

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.16, $0.05 better than the analyst estimate of $0.11. Revenue for the quarter came in at $87.3 million versus the consensus estimate of $85.3 million.

AngioDynamics sees Q2 2014 EPS of $0.14-$0.17, versus the consensus of $0.16. AngioDynamics sees Q2 2014 revenue of $89-92 million, versus the consensus of $91.69 million.

AngioDynamics sees FY2015 EPS of $0.65-$0.71, versus the consensus of $0.67. AngioDynamics sees FY2015 revenue of $362-368 million, versus the consensus of $364.98 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c